38 related articles for article (PubMed ID: 29580038)
1. Epigenetic Downregulation and Growth Inhibition of IGFBP7 in Gastric Cancer.
Kim J; Kim WH; Byeon SJ; Lee BL; Kim MA
Asian Pac J Cancer Prev; 2018 Mar; 19(3):667-675. PubMed ID: 29580038
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of molecular subtypes and clonal selection during establishment of patient-derived tumor xenografts from gastric adenocarcinoma.
Peille AL; Vuaroqueaux V; Wong SS; Ting J; Klingner K; Zeitouni B; Landesfeind M; Kim WH; Lee HJ; Kong SH; Wulur I; Bray S; Bronsert P; Zanella N; Donoho G; Yang HK; Fiebig HH; Reinhard C; Aggarwal A
Commun Biol; 2020 Jul; 3(1):367. PubMed ID: 32647357
[TBL] [Abstract][Full Text] [Related]
3. Downregulated IGFBP7 facilitates liver metastasis by modulating epithelial‑mesenchymal transition in colon cancer.
Li Y; Xi Y; Zhu G; Jia J; Huang H; Liu Y; Guo Y; Liu L
Oncol Rep; 2019 Nov; 42(5):1935-1945. PubMed ID: 31545454
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Value of Serum Insulin-Like Growth Factor Binding Protein 7 (IGFBP7) in Colorectal Cancer.
Qiu B; Chu LY; Li XX; Peng YH; Xu YW; Xie JJ; Chen XY
Onco Targets Ther; 2020; 13():12131-12139. PubMed ID: 33262611
[TBL] [Abstract][Full Text] [Related]
5. Insulin Growth Factor Binding Protein 7 (IGFBP7)-Related Cancer and IGFBP3 and IGFBP7 Crosstalk.
Jin L; Shen F; Weinfeld M; Sergi C
Front Oncol; 2020; 10():727. PubMed ID: 32500027
[TBL] [Abstract][Full Text] [Related]
6. The Diagnostic Value of Serum IGFBP7 in Patients with Esophageal Squamous Cell Carcinoma.
Huang X; Hong C; Peng Y; Yang S; Huang L; Liu C; Chen L; Chu L; Xu L; Xu Y
J Cancer; 2019; 10(12):2687-2693. PubMed ID: 31258777
[TBL] [Abstract][Full Text] [Related]
7. HOXC10 overexpression promotes cell proliferation and migration in gastric cancer.
Kim J; Bae DH; Kim JH; Song KS; Kim YS; Kim SY
Oncol Rep; 2019 Jul; 42(1):202-212. PubMed ID: 31115563
[TBL] [Abstract][Full Text] [Related]
8. IGFBP7 Drives Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition in Lung Cancer.
Wu SG; Chang TH; Tsai MF; Liu YN; Hsu CL; Chang YL; Yu CJ; Shih JY
Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30609749
[TBL] [Abstract][Full Text] [Related]
9. IGFBP7 is associated to prognosis and could suppress cell survival in cholangiocarcinoma.
Yue C; Yang M; Tian Q; Mo F; Peng J; Ma Y; Huang Y; Wang D; Wang Y; Hu Z
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):817-825. PubMed ID: 29991293
[TBL] [Abstract][Full Text] [Related]
10. IGFBP7 promotes gastric cancer by facilitating epithelial-mesenchymal transition of gastric cells.
Wang J; Wang X; Liu Z; Li S; Yin W
Heliyon; 2024 May; 10(10):e30986. PubMed ID: 38778944
[TBL] [Abstract][Full Text] [Related]
11. Gastric Cancer in the Era of Epigenetics.
Christodoulidis G; Koumarelas KE; Kouliou MN; Thodou E; Samara M
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542354
[TBL] [
